| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |